Superovulation.
Development of a superovulation technique that is successful, safe, and commercially available would revolutionize the equine breeding industry. However, the reality is that ovulation rates for mares following existing superovulatory treatment are much lower than for cattle. This dichotomy has been attributed to the relatively limited area available in the ovulation fossa for ovulation to occur, combined with the large size of the equine preovulatory follicle. In addition, the number of ovulations in the mare may be limited physiologically by the size of the follicular cohort that may be rescued by administration of gonadotropins. Clearly, additional research effort is necessary to optimize superovulation treatment regimens in the mare.
McCue
P M
PM
Animal Reproduction and Biotechnology Laboratory, Colorado State University, Fort Collins, USA.
D000818:Animals; D004624:Embryo Transfer / Q000379:methods / Q000662:veterinary; D005260:Female; D005307:Fertilization in Vitro / Q000379:methods / Q000662:veterinary*; D005640:Follicle Stimulating Hormone / Q000494:pharmacology; D007987:Gonadotropin-Releasing Hormone / Q000494:pharmacology; D006064:Gonadotropins, Equine / Q000494:pharmacology; D006736:Horses / Q000502:physiology*; D009865:Oocytes / Q000166:cytology / Q000502:physiology; D011247:Pregnancy; D013480:Superovulation / Q000187:drug effects / Q000502:physiology*
D006064:Gonadotropins, Equine; D007987:Gonadotropin-Releasing Hormone; D005640:Follicle Stimulating Hormone